{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-121182","form_type":"8-K","ticker":"ZBIO","cik":"0001953926","company_name":"Zenas BioPharma, Inc.","filed_at":"2025-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.140575+00:00","generated_at":"2026-05-16T13:16:02.158728+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Zenas BioPharma adopts 2026 Inducement Plan for up to 1M shares for new hires","bullets":["Plan reserves 1,000,000 shares of common stock for equity awards to new employees as hiring inducements.","Approved Dec 10, 2025 by Board; requires Compensation Committee or independent director approval per Nasdaq Rule 5635(c)(4).","Plan exempt from stockholder approval; grants include non-statutory stock options, SARs, RSUs, and restricted stock.","Eligible individuals are new hires or rehires after a bona fide break in employment."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-121182","json":"https://secwatch.observer/filing/0001104659-25-121182.json","markdown":"https://secwatch.observer/filing/0001104659-25-121182.md","text":"https://secwatch.observer/filing/0001104659-25-121182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1953926/000110465925121182/0001104659-25-121182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1953926/000110465925121182/tm2533427d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:16:02.158728+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}